Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.

Abstract

We report our experience in the follow-up of 63 patients with advanced prostate adenocarcinoma. We used prostate-specific antigen and prostatic acid phosphatase in 27 patients; in 36 patients we evaluated osteocalcin and bone isoenzyme of alkaline phosphatase, two markers of bone metabolism which seem to be good markers in the follow-up of patients with… (More)

Topics

Cite this paper

@article{Curatolo1992AdvancedPC, title={Advanced prostate cancer follow-up with prostate-specific antigen, prostatic acid phosphatase, osteocalcin and bone isoenzyme of alkaline phosphatase.}, author={Christian Curatolo and G M Ludovico and Mario Correale and Arcangelo Pagliarulo and Isabella Abbate and E Cirrillo Marucco and A. Barletta}, journal={European urology}, year={1992}, volume={21 Suppl 1}, pages={105-7} }